Advances in Parvovirus Research 2022
dc.contributor.editor | Gallinella, Giorgio | |
dc.date.accessioned | 2023-11-30T20:53:58Z | |
dc.date.available | 2023-11-30T20:53:58Z | |
dc.date.issued | 2023 | |
dc.identifier | ONIX_20231130_9783036594484_251 | |
dc.identifier.uri | https://directory.doabooks.org/handle/20.500.12854/128799 | |
dc.description.abstract | Viruses in the Parvoviridae family constitutes a most diverse and intriguing field of research. Parvoviruses have a long evolutionary history and, beneath an apparent simplicity and uniformity, can differ widely in structure, genome organization and expression, virus–cell interaction, and impact on the host. In addition to interest in the study of basic virology, the translational implications of research on parvoviruses are relevant since many viruses are important human and veterinary pathogens, while other viruses can be engineered as tools for oncolytic therapy or as sophisticated gene delivery vectors. Exploring the diversity and the inherent complexity in the biology of these apparently simple viruses is an ongoing commitment for the scientific community to address. This Special Issue entitled ‘Advances in Parvovirus Research 2022’ continued the series dedicated to research on viruses belonging to the Parvoviridae family and collected the latest contributions in the field of parvovirus research. | |
dc.language | English | |
dc.subject.classification | thema EDItEUR::M Medicine and Nursing | en_US |
dc.subject.classification | thema EDItEUR::M Medicine and Nursing::MB Medicine: general issues::MBN Public health and preventive medicine::MBNS Epidemiology and Medical statistics | en_US |
dc.subject.other | parvovirus B19 | |
dc.subject.other | synthetic genome | |
dc.subject.other | genetic engineering | |
dc.subject.other | replicon unit | |
dc.subject.other | functional complementation | |
dc.subject.other | B19V | |
dc.subject.other | VP1u | |
dc.subject.other | VP1uR | |
dc.subject.other | receptor | |
dc.subject.other | tropism | |
dc.subject.other | primate erythroparvovirus | |
dc.subject.other | simian erythroparvovirus | |
dc.subject.other | rhesus erythroparvovirus | |
dc.subject.other | pig-tailed erythroparvovirus | |
dc.subject.other | Benzonase® | |
dc.subject.other | acute infection | |
dc.subject.other | persistent infection | |
dc.subject.other | viral DNA load | |
dc.subject.other | oncolytic virus immunotherapy | |
dc.subject.other | protoparvovirus H-1PV | |
dc.subject.other | virus host interactions | |
dc.subject.other | virus cell entry | |
dc.subject.other | galectin-1 | |
dc.subject.other | laminin γ1 | |
dc.subject.other | adeno-associated virus | |
dc.subject.other | AAV | |
dc.subject.other | classification | |
dc.subject.other | genotype | |
dc.subject.other | serotype | |
dc.subject.other | intraspecies | |
dc.subject.other | pairwise genetic distance | |
dc.subject.other | recombination | |
dc.subject.other | porcine parvovirus | |
dc.subject.other | virus-like particles | |
dc.subject.other | diagnostic | |
dc.subject.other | I-ELISA | |
dc.subject.other | parvovirus | |
dc.subject.other | capsid | |
dc.subject.other | AMDV | |
dc.subject.other | PARV4 | |
dc.subject.other | cryo-EM | |
dc.subject.other | Amdoparvovirus | |
dc.subject.other | Tetraparvovirus | |
dc.subject.other | pathogen | |
dc.subject.other | CPV-2 | |
dc.subject.other | FPV | |
dc.subject.other | illegal trade | |
dc.subject.other | companion animals | |
dc.subject.other | wildlife | |
dc.subject.other | spillover | |
dc.subject.other | porcine parvovirus 1 | |
dc.subject.other | Africa | |
dc.subject.other | epidemiology | |
dc.subject.other | phylogeography | |
dc.subject.other | phylogeny | |
dc.subject.other | VP2 | |
dc.subject.other | H1-PV | |
dc.subject.other | infection | |
dc.subject.other | oncolytic virus | |
dc.subject.other | anticancer gene | |
dc.subject.other | cancer gene therapy | |
dc.subject.other | cancer | |
dc.subject.other | Parvovirus B19 | |
dc.subject.other | genetic diversity | |
dc.subject.other | viral quasispecies | |
dc.subject.other | Next Generation Sequencing | |
dc.subject.other | Shannon Entropy | |
dc.subject.other | cluster analysis | |
dc.subject.other | skunk amdoparvovirus | |
dc.subject.other | striped skunk | |
dc.subject.other | next generation sequencing | |
dc.subject.other | virus surveillance | |
dc.subject.other | HIV infection | |
dc.subject.other | hemolysis | |
dc.subject.other | hereditary spherocytosis | |
dc.subject.other | parvoviruses | |
dc.subject.other | DNA damage response | |
dc.subject.other | Minute Virus of Mice | |
dc.subject.other | immunity | |
dc.subject.other | evolution | |
dc.subject.other | paleovirology | |
dc.subject.other | endogenous viral elements | |
dc.subject.other | bocavirus | |
dc.subject.other | CnMV | |
dc.subject.other | PBoV | |
dc.subject.other | RBoV | |
dc.subject.other | canine parvovirus type 2 | |
dc.subject.other | molecular epidemiology | |
dc.subject.other | Protoparvovirus carnivoran1 | |
dc.subject.other | virus evolution | |
dc.subject.other | Parvoviridae | |
dc.subject.other | international workshop | |
dc.subject.other | conference report | |
dc.title | Advances in Parvovirus Research 2022 | |
dc.type | book | |
oapen.identifier.doi | 10.3390/books978-3-0365-9449-1 | |
oapen.relation.isPublishedBy | 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 | |
oapen.relation.isbn | 9783036594484 | |
oapen.relation.isbn | 9783036594491 | |
oapen.pages | 288 | |
oapen.place.publication | Basel |
Files in this item
Files | Size | Format | View |
---|---|---|---|
There are no files associated with this item. |